RxDoctor Payments Data

Tammy McWhirter, NP

Family · Athens, ALNPI 1710517206

Payments from drug & device makers

$411in general payments, 2019–2025

Across 29 payments — averaging $14.17 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$217
  • Lilly USA, LLC$84
  • Novo Nordisk$29
  • Daiichi Sankyo Inc.$21
  • Biohaven Pharmaceutical Holding Company Ltd.$20
  • Boehringer Ingelheim$15
  • plus $25 from 2 others

What the payments were for

  • Food & beverage$411100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$411 in reported general payments places this provider in the 45th percentile of 3,415 family providers in Alabama.

See all family providers in Alabama

Medicare billing

Part B allowed, 2024
$6,824
Medicare patients
60
Services billed
160

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
JardianceEmpagliflozin19$20,482
TrulicityDulaglutide19$17,805
MounjaroTirzepatide14$15,302
FarxigaDapagliflozin Propanediol21$14,686
Trelegy ElliptaFluticasone/Umeclidin/Vilanter12$10,024
Breztri AerosphereBudesonide/Glycopyr/Formoterol12$7,767
Levothyroxine Sodium64$930
Omeprazole46$882
Rosuvastatin Calcium39$825
Lisinopril69$769
Albuterol Sulfate HfaAlbuterol Sulfate32$746
Metformin Hcl56$654
Ezetimibe16$645
Atorvastatin Calcium37$572
Duloxetine Hcl21$428

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCTrulicity, Mounjaro$84$33,10733 claims
AstraZenecaFarxiga, Breztri Aerosphere$12$22,45433 claims
Boehringer IngelheimJardiance$15$20,48219 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 45th percentile of 3,415 family providers in Alabama.

Other family in Athens

See the full list for Alabama

Where these figures come from

Is this you, or does something look wrong? →